Literature DB >> 28434343

Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome.

Paolo Milani1, Marco Basset1, Francesca Russo1, Andrea Foli1, Francesca Lavatelli1, Mario Nuvolone1, Giovanni Ferraro1, Giovanni Palladini1, Giampaolo Merlini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28434343     DOI： 10.1080/13506129.2017.1293517

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  3 in total

1.  Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.

Authors:  Surbhi Sidana; Eli Muchtar; M Hasib Sidiqi; Dragan Jevremovic; Angela Dispenzieri; Wilson Gonsalves; Francis Buadi; Martha Q Lacy; Suzanne R Hayman; Taxiarchis Kourelis; Prashant Kapoor; Ronald S Go; Rahma Warsame; Nelson Leung; S Vincent Rajkumar; Robert A Kyle; Morie A Gertz; Shaji K Kumar
Journal:  Am J Hematol       Date:  2020-02-14       Impact factor: 10.047

2.  Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Authors:  S Sidana; N Tandon; A Dispenzieri; M A Gertz; F K Buadi; M Q Lacy; D Dingli; A L Fonder; S R Hayman; M A Hobbs; W I Gonsalves; Y L Hwa; P Kapoor; R A Kyle; N Leung; R S Go; J A Lust; S J Russell; S R Zeldenrust; S V Rajkumar; S K Kumar
Journal:  Leukemia       Date:  2017-09-18       Impact factor: 11.528

Review 3.  Biomarkers in AL Amyloidosis.

Authors:  Despina Fotiou; Foteini Theodorakakou; Efstathios Kastritis
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.